Literature DB >> 24326566

Cutaneous drug delivery: an update.

Thanh-Nga T Tran1.   

Abstract

Cutaneous delivery of therapeutics represents a proven and attractive option for treating a variety of dermatologic conditions with minimal systemic side effects. Although there have been many innovations in drug delivery systems, the number of effective cutaneous drugs remains small, primarily because of the stratum corneum permeability barrier. Overcoming this barrier safely and reversibly to deliver large hydrophilic drugs cutaneously is one of the major challenges in the field of dermatologic therapy.

Mesh:

Year:  2013        PMID: 24326566     DOI: 10.1038/jidsymp.2013.28

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  3 in total

1.  Doxorubicin liposomes as an investigative model to study the skin permeation of nanocarriers.

Authors:  Cedar H A Boakye; Ketan Patel; Mandip Singh
Journal:  Int J Pharm       Date:  2015-04-21       Impact factor: 5.875

Review 2.  Potential for Tight Junction Protein-Directed Drug Development Using Claudin Binders and Angubindin-1.

Authors:  Yosuke Hashimoto; Keisuke Tachibana; Susanne M Krug; Jun Kunisawa; Michael Fromm; Masuo Kondoh
Journal:  Int J Mol Sci       Date:  2019-08-17       Impact factor: 5.923

3.  Enhancing the in vivo transdermal delivery of gold nanoparticles using poly(ethylene glycol) and its oleylamine conjugate.

Authors:  Pa Fan Hsiao; Sydney Peng; Ting-Cheng Tang; Shuian-Yin Lin; Hsieh-Chih Tsai
Journal:  Int J Nanomedicine       Date:  2016-05-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.